Small Molecules
28 January 2013
Nimbus Discovery Presents Preclinical Data on Sought-After ACC Inhibitors for the Treatment of Metabolic Syndrome and Diabetes27 January 2013
Belinostat has favorable safety profile in PTCL BELIEF study24 January 2013
CHANTIX (varenicline) Demonstrates Efficacy in Smokers Who Previously Attempted to Quit Smoking with CHANTIX24 January 2013
Curis Announces Dosing of First Patient in Phase I Clinical Trial of Dual PI3 Kinase and HDAC Inhibitor CUDC-90724 January 2013
Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide, a Novel Low-Dose Prodrug for the Treatment of HIV24 January 2013
Novartis drug Exjade first treatment approved by FDA for chronic iron overload in patients with non-transfusion-dependent thalassemia23 January 2013
EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma23 January 2013
Santarus and VeroScience Announce Publication of Positive Data from Pivotal CYCLOSET (bromocriptine mesylate) Efficacy Study23 January 2013
Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder23 January 2013
ABRAXANE Plus Gemcitabine Demonstrates Significant Survival Advantage in Phase III Study of Patients with Advanced Pancreatic Cancer23 January 2013
FDA Issues Complete Response Letter for RYTARY (Carbidopa and Levodopa) Extended-Release Capsules (IPX066) New Drug Application21 January 2013
Investigator sponsored Phase I/II study of AXL1717 in patients with brain tumors started in the US18 January 2013
Santhera Receives a Negative Opinion on its Marketing Authorization Application for Raxone. Plans to Request Re-examination17 January 2013
GlycoMimetics Completes Enrollment in Phase 2 Sickle Cell Disease Study with Lead Drug Candidate GMI-107017 January 2013
Boehringer Ingelheim enrols first patients in pivotal Phase III interferon-free hepatitis C trial programmeNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports